Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Sep'24
Net Sales
160.93
145.30
119.85
167.41
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
160.93
145.30
119.85
167.41
0.00
Raw Material Cost
118.91
100.44
91.08
125.01
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-7.35
4.41
-6.66
-1.23
0.00
Employee Cost
8.15
8.30
7.63
9.70
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.72
3.67
3.64
4.59
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
11.16
6.14
7.17
12.09
0.00
Total Expenditure (Excl Depreciation)
134.59
122.96
102.86
150.16
0.00
Operating Profit (PBDIT) excl Other Income
26.34
22.34
16.99
17.25
0.00
Other Income
0.00
0.00
0.00
0.00
0.00
Operating Profit (PBDIT)
26.34
22.34
16.99
17.25
0.00
Interest
10.55
7.73
6.53
8.15
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
15.79
14.61
10.46
9.10
0.00
Depreciation
1.78
1.89
1.42
1.84
0.00
Profit Before Tax
14.00
12.71
9.04
7.26
0.00
Tax
3.52
3.27
2.27
1.26
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
10.48
9.43
6.77
6.00
0.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
10.48
9.43
6.77
6.00
0.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
10.48
9.43
6.77
6.00
0.00
Equity Capital
4.72
4.72
4.72
4.72
4.72
Face Value
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
22.2
19.98
14.34
12.71
0.0
Diluted Earnings per share
22.19
19.98
14.33
12.71
0.0
Operating Profit Margin (Excl OI)
16.47%
15.56%
14.23%
10.43%
0.0%
Gross Profit Margin
9.87%
10.17%
8.76%
5.5%
0.0%
PAT Margin
6.55%
6.57%
5.67%
3.63%
0.0%
Public Share Holdings (%)
51.07%
51.07%
51.07%
51.07%
50.84%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2025 is 57.04% vs 17.53% in Dec 2024
Standalone Net Profit
YoY Growth in quarter ended Dec 2025 is 96.62% vs 26.30% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2025 is 99.09% vs 25.88% in Dec 2024
Interest
YoY Growth in quarter ended Dec 2025 is 111.00% vs 32.63% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
Compare Quarterly Results Of Fredun Pharma With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
160.93
110.48
50.45
45.66%
Other Operating Income
0.00
0.00
0.00
Total Operating income
160.93
110.48
50.45
45.66%
Raw Material Cost
118.91
42.51
76.40
179.72%
Purchase of Finished goods
0.00
10.44
-10.44
-100.00%
(Increase) / Decrease In Stocks
-7.35
7.37
-14.72
-199.73%
Employee Cost
8.15
21.84
-13.69
-62.68%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
3.72
-0.01
3.73
37,300.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
11.16
20.80
-9.64
-46.35%
Total Expenditure (Excl Depreciation)
134.59
102.95
31.64
30.73%
Operating Profit (PBDIT) excl Other Income
26.34
7.53
18.81
249.80%
Other Income
0.00
2.49
-2.49
-100.00%
Operating Profit (PBDIT)
26.34
10.02
16.32
162.87%
Interest
10.55
3.13
7.42
237.06%
Exceptional Items
0.00
4.66
-4.66
-100.00%
Gross Profit (PBDT)
15.79
11.55
4.24
36.71%
Depreciation
1.78
4.11
-2.33
-56.69%
Profit Before Tax
14.00
7.44
6.56
88.17%
Tax
3.52
-3.10
6.62
213.55%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
10.48
10.53
-0.05
-0.47%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
10.48
10.53
-0.05
-0.47%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
-0.16
0.16
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
10.48
10.69
-0.21
-1.96%
Equity Capital
4.72
38.21
-33.49
-87.65%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
22.20
0.28
21.92
7,828.57%
Diluted Earnings per share
22.19
0.28
21.91
7,825.00%
Operating Profit Margin (Excl OI)
16.47%
6.82%
0.00
9.65%
Gross Profit Margin
9.87%
10.45%
0.00
-0.58%
PAT Margin
6.55%
9.53%
0.00
-2.98%
Public Share Holdings (%)
51.07%
0.00%
51.07
51.07%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 159.93 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is 11.38% vs 20.26% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 57.04% vs 17.53% in Dec 2024
Quarterly - Standalone Net Profit
Standalone Net Profit 10.48 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is 7.71% vs 43.72% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 96.62% vs 26.30% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.34 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is 17.85% vs 31.55% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 99.09% vs 25.88% in Dec 2024
Quarterly - Interest
Interest 10.55 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is 36.48% vs 18.38% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 111.00% vs 32.63% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.47%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
